Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-17

FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)

View source ↗

Summary

The FDA approved a supplemental application for QUTENZA (capsaicin) submitted by Averitas Pharma Inc. The document does not specify the exact nature of the supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

SUPPL AP for QUTENZA (CAPSAICIN)